The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors BioMarin Pharmaceutical Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Designation or determination (2) (-) Designation or determination (2) ARTG (12) ARTG (12) Prescription medicine registration (4) Prescription medicine registration (4) Australian Public Assessment Report (AusPAR) (3) Australian Public Assessment Report (AusPAR) (3) Prescription medicine decision summary (2) Prescription medicine decision summary (2) Date 2023 (2) 2023 (2) Search Filters applied:Designation or determinationClear all Sponsor content2 result(s) found, displaying 1 to 2 Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd) 14 February 2023 Designation or determination Priority review Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd) 10 January 2023 Designation or determination Orphan drug
Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd) 14 February 2023 Designation or determination Priority review
Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd) 10 January 2023 Designation or determination Orphan drug